VBI Vaccines
VBIV
#10177
Rank
A$2.99 M
Marketcap
$0.10
Share price
0.00%
Change (1 day)
-87.92%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -A$0.13 Billion

According to VBI Vaccines 's latest financial reports the company's current earnings are A$9.41 Million. In 2023 the company made an earning of -A$0.15 Billion, an increase over its 2022 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion-14.69%
2023 -A$0.15 Billion-18.06%
2022 -A$0.19 Billion62.43%
2021 -A$0.12 Billion50.88%
2020 -A$73.97 Million-15.66%
2019 -A$87.71 Million-13.82%
2018 -A$0.11 Billion61.32%
2017 -A$63.09 Million57.8%
2016 -A$39.98 Million-67.39%
2015 -A$0.13 Billion1527.36%
2014 -A$7.54 Million36.21%
2013 -A$5.54 Million-63.91%
2012 -A$15.33 Million-59.19%
2011 -A$37.56 Million227.23%
2010 -A$11.48 Million1741.53%
2009 -A$0.63 Million14.52%
2008 -A$0.55 Million-42.93%
2007 -A$0.96 Million21.8%
2006 -A$0.79 Million172.39%
2005 -A$0.29 Million115.38%
2004 -A$0.14 Million-42.27%
2003 -A$0.24 Million109.27%
2002 -A$0.12 Million17.89%
2001 -A$0.1 Million-369.64%
2000 A$0.03 M-69.24%
1999 A$0.11 M12.77%
1998 A$0.1 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$29.05 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 36.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$71.7 Million-46.00%๐Ÿ‡บ๐Ÿ‡ธ USA